Tom Lehrer's guide to design of SARS-CoV-3 main protease inhibitors for treatment of COVID-32

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

First cited

—

Most recent

—

Rank this month

not ranked

Links from this post

22

Words captured

1,124